NCT04529941View on ClinicalTrials.gov

Using Electrical Nerve Stimulation to Control Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

November 24, 2021

Primary Completion Date

September 4, 2024

Study Completion Date

September 25, 2024

Conditions
Atrial Fibrillation
Interventions
DEVICE

Device Implant with Active Treatment

ScNS at 3.5mA output for 2 weeks

DEVICE

Device Implant without Active Treatment

No device output for 2 weeks

Trial Locations (1)

90048

CedarsSinaiMC, Los Angeles

All Listed Sponsors
collaborator

Indiana University

OTHER

collaborator

National Institutes of Health (NIH)

NIH

lead

Cedars-Sinai Medical Center

OTHER

NCT04529941 - Using Electrical Nerve Stimulation to Control Atrial Fibrillation | Biotech Hunter | Biotech Hunter